Evaluation of Quality-of-Life (QOL) Assessment in Patients with Advanced Solid Malignancies as Screening Tool- Pilot Study on Implications on Eligibility and Adverse Events

PrintE-mail
Title Evaluation of Quality-of-Life (QOL) Assessment in Patients with Advanced Solid Malignancies as Screening Tool- Pilot Study on Implications on Eligibility and Adverse Events
Contact FS
Principal Investigator Grace Dy, MD
Study Number 192811
PhasePilot
Summary This is a quality-of-life questionnaire study.  Patients on a Phase I trial will take this survey at 4 separate times throughout their treatment.
Eligibility
  • Must be consented to a Phase I therapeutic study. 
  • Must sign consent. 
  • Must be over 18. 
  • Must have advanced solid malignancies.